Meeting Highlights from American Diabetes Association 77th Annual Scientific Sessions

June 9-13, 2017
San Diego, CA

Medical and health professionals involved in diabetes research and care arrived in San Diego, California to "Experience New Horizons in Diabetes" at the 2017 annual meeting, which attracted more than 15,000 professionals from around the world.

Practitioners and researchers met to share insights into cutting-edge research, treatment recommendations, and advances in the management of diabetes.

EndocrineWeb sought out clinical topics that have not been covered already in the research briefs and reflect concerns that patients have clearly identified as topics their endocrinologist should be prepared to address with them.

Presentations by Jeremy Pettus, MD and William H. Polonsky, PhD, CDE, with commentary by Joni Beck, PharmD, CDE, offered a healthy consideration of the role of continuous glucose monitoring in a variety of patients with diabetes—some clearly benefitting more than others.

A consensus of pediatric endocrinologists put out a call for earlier diagnosis and management of diabetes in children heralded by Phil Zeitler MD, PhD, and Carla Greenbaum, MD as the matter of lowering the risk of complications requires greater attention, particularly cardiovascular risk, and the sooner the better.

The session on the challenges of making insulin more affordable was addressed by Kasia Lipska, MD, Alan Carter, PharmD, David Robbins, MD, and Robert Ratner, MD, with commentary by Scott Isaacs, MD. A key takeaway message was offered by Dr. Robbins, “when interpreting studies, for instance, it's important to differentiate statistically significant from clinically significant.” 

In a compelling session on common complications of type 1 diabetes, concerns of patients vary from those focused on during office visits, according to presenters: Aruna V. Sarma, PhD, MHA, Michael Albo, MD, and Hunter Wessells, MD with commentary by Elena A. Christofides, MD. The takeway message was a need for clinical empathy for patients' daily struggles.  Whereas clinicians typically focus their 15-minute visit on managing blood sugar and warning against potential complications, such as retinopathy, neuropathy and foot ulcers, patients are struggling with loss of sexual libido and bladder that affect their quality of lives on a day to day basis, necessitating medical attention at least as much as the clinical concerns. 

Diabetes affects nearly 30 million children and adults in the United States and contributes to the deaths of more than 230,000 individuals annually. The ADA scientific sessions offered research to advance the clinical management of gestational diabetes, prediabetes and undiagnosed diabetes as well as type 1 and type 2 diabetes.

Last updated on
First Article From This Meeting:
Call for Better Management of Diabetes in Youth
SHOW MAIN MENU
SHOW SUB MENU